ArticleMediterranean journal of rheumatology2026
Phenotypic Heterogeneity in Familial Takayasu Arteritis Across Two Families: A Case-Based Review.
Article in Mediterranean journal of rheumatology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Takayasu arteritis (TAK) is a rare large-vessel vasculitis that predominantly affects young women. Familial cases are uncommon but suggest a possible genetic predisposition. Case Report: We describe five familial TAK cases from two families. In the first, two sisters had distinct disease patterns: one with severe supra-aortic involvement (Hata IIa), requiring intensive immunosuppression and vascular interventions; the other with isolated abdominal aortic disease (Hata IV), successfully managed with standard therapy. In the second family, three siblings presented with varying severity. One sister had mild disease responsive to therapy, whereas another developed rapidly progressive TAK with multivessel involvement, necessitating complex surgical management and ultimately succumbing to COVID-19 complications. Their brother presented with extensive Hata V involvement and achieved remission following brief medical therapy. Conclusion: Familial TAK demonstrates marked clinical and radiological heterogeneity, even among first-degree relatives. These findings underscore the importance of clinical vigilance and prompt evaluation for relatives who develop suggestive symptoms, to enable timely diagnosis and improve clinical outcomes.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.